ORC3 (origin recognition complex subunit 3) Activators belong to a specialized class of biomolecular agents that interact with a specific protein component of the Origin Recognition Complex (ORC), namely ORC3. The Origin Recognition Complex is a crucial part of the cellular machinery in eukaryotic organisms, playing a pivotal role in DNA replication initiation. The ORC is a six-protein complex (ORC1-6) that binds to origins of replication in a sequence-independent manner, which is a prerequisite for the assembly of additional replication initiation factors. Among these subunits, ORC3 is one of the most conserved across different species, underlining its importance in the initiation of replication.
These activators may interact directly with the ORC3 subunit or modulate its activity indirectly through other molecular pathways. This interaction or modulation results in increased ORC3 activity, which, in turn, leads to an enhanced ability of the ORC to recognize and bind to origins of replication. This process facilitates the recruitment of additional proteins required for the formation of the pre-replicative complex, which is essential for the initiation of DNA replication. The nature of the interactions and the exact mechanisms through which ORC3 Activators increase ORC3 activity can vary significantly, depending on the specific chemical properties of the activator molecules. Thus, ORC3 Activators represent a diverse class of biomolecules with the shared characteristic of enhancing ORC3 function and, by extension, the DNA replication initiation process.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING | 
|---|---|---|---|---|---|---|
| Purvalanol A | 212844-53-6 | sc-224244 sc-224244A | 1 mg 5 mg | $71.00 $291.00 | 4 | |
| Inhibits cyclin-dependent kinases, potentially enabling cell cycle progression and indirectly prompting ORC3 activation. | ||||||
| Roscovitine | 186692-46-6 | sc-24002 sc-24002A | 1 mg 5 mg | $92.00 $260.00 | 42 | |
| Inhibits CDKs, possibly facilitating cell cycle regulation and indirectly spurring ORC3 activation. | ||||||
| L-Mimosine | 500-44-7 | sc-201536A sc-201536B sc-201536 sc-201536C | 25 mg 100 mg 500 mg 1 g | $35.00 $86.00 $216.00 $427.00 | 8 | |
| Arrests cells in late G1 phase, potentially altering timing of DNA replication and indirectly catalyzing ORC3 activation. | ||||||
| Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $76.00 $255.00 | 18 | |
| Inhibits ribonucleotide reductase, leading to decreased deoxyribonucleotide pools and potentially stalling DNA replication, which may indirectly instigate ORC3 activation. | ||||||
| Aphidicolin | 38966-21-1 | sc-201535 sc-201535A sc-201535B | 1 mg 5 mg 25 mg | $82.00 $300.00 $1082.00 | 30 | |
| Inhibits DNA polymerase α and δ, potentially facilitating DNA replication and indirectly triggering ORC3 activation. | ||||||
| Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $32.00 $170.00 $385.00 | 63 | |
| Inhibits topoisomerase II, preventing re-ligation of DNA strands, potentially encouraging DNA replication and indirectly promoting ORC3 activation. | ||||||
| Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $57.00 $182.00 $92.00 | 21 | |
| Inhibits topoisomerase I, preventing DNA unwinding necessary for replication, which can indirectly catalyze ORC3 activation. | ||||||
| Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $36.00 $149.00 | 11 | |
| Inhibits thymidylate synthase, potentially promoting DNA synthesis which can indirectly stimulate ORC3 activation. | ||||||
| Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
| Binds to DNA and inhibits RNA synthesis, which can indirectly catalyze DNA replication and ORC3 activation. | ||||||
| Mitomycin C | 50-07-7 | sc-3514A sc-3514 sc-3514B | 2 mg 5 mg 10 mg | $65.00 $99.00 $140.00 | 85 | |
| Cross-links DNA, potentially disrupting DNA replication and indirectly triggering ORC3 activation. | ||||||